Godavari Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE362C01012
  • NSEID:
  • BSEID: 530317
INR
81.91
9.48 (13.09%)
BSENSE

Dec 22

BSE+NSE Vol: 17.64 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 765253,
    "name": "Godavari Drugs",
    "stock_name": "Godavari Drugs",
    "full_name": "Godavari Drugs Ltd",
    "name_url": "stocks-analysis/godavari-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "81.91",
    "chg": 9.48,
    "chgp": "13.09%",
    "dir": 1,
    "prev_price": "72.43",
    "mcapval": "61.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530317,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE362C01012",
    "curr_date": "Dec 22",
    "curr_time": "",
    "bse_nse_vol": "17.64 k",
    "exc_status": "Active",
    "traded_date": "Dec 22, 2025",
    "traded_date_str": "2025 12 22",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/godavari-drugs-765253-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Godavari Drugs Stock Hits 52-Week Low at Rs.69.7 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-falls-to-52-week-low-of-rs697-amidst-continued-weakness-3753811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3753811.png",
        "date": "2025-12-09 11:23:32",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.69.7, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance over the past year."
      },
      {
        "title": "Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-stock-falls-to-52-week-low-of-rs7031-amid-continued-weak-performance-3751223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3751223.png",
        "date": "2025-12-08 11:00:57",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.70.31 today, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year."
      },
      {
        "title": "Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-stock-hits-52-week-low-amidst-continued-downtrend-3751222",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3751222.png",
        "date": "2025-12-08 11:00:37",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.70.31, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical and biotechnology company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year."
      },
      {
        "title": "Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-falls-to-52-week-low-amid-continued-weak-performance-3751221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3751221.png",
        "date": "2025-12-08 11:00:21",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.70.31, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year."
      },
      {
        "title": "Godavari Drugs Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-trends-3750166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_mojoScore_3750166.png",
        "date": "2025-12-07 10:10:03",
        "description": "Godavari Drugs has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The pharmaceutical microcap’s recent assessment highlights a cautious stance driven by subdued sales growth, persistent negative earnings, and bearish trading patterns."
      },
      {
        "title": "Godavari Drugs Falls to 52-Week Low of Rs.72.11 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-stock-hits-52-week-low-at-rs7211-amidst-continued-downtrend-3748950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3748950.png",
        "date": "2025-12-05 11:52:55",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.72.11, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance over the past year."
      },
      {
        "title": "Godavari Drugs Falls to 52-Week Low of Rs.73.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-stock-hits-52-week-low-amidst-continued-downtrend-3740887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3740887.png",
        "date": "2025-12-02 09:26:41",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.73.2, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market factors that have influenced its performance."
      },
      {
        "title": "Godavari Drugs Stock Hits 52-Week Low at Rs.74 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-stock-hits-52-week-low-at-rs74-amidst-continued-downtrend-3738445",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3738445.png",
        "date": "2025-12-01 11:19:32",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.74, marking a significant milestone in its ongoing price decline. The stock’s performance over the past year reflects a challenging period for the company within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Godavari Drugs Stock Falls to 52-Week Low of Rs.74 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-stock-hits-52-week-low-at-rs74-amidst-continued-downtrend-3738443",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3738443.png",
        "date": "2025-12-01 11:19:26",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.74, marking a significant milestone in its ongoing price decline. This development reflects a continuation of the stock’s subdued performance over the past year, contrasting with broader market gains."
      }
    ],
    "total": 150,
    "sid": "765253",
    "stock_news_url": "https://www.marketsmojo.com/news/godavari-drugs-765253"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Nov-2025",
      "details": "Newspaper publication of Unaudited Financial Results for the quarter and half year ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financials Results Pursuant To Regulation 33 Of The SEBI(LODR) Regulations 2015 For The Quarter And Half Year Ended 30Th September 2025",
      "datetime": "14-Nov-2025",
      "details": "Unaudited Financial Statement for the Quarter and Half Year Ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Unaudited Financial Statement For The Half-Year Ended 30Th September 2025",
      "datetime": "14-Nov-2025",
      "details": "Unaudited Financial Statement For The Half-Year Ended 30Th September 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Nov-2025 | Source : BSE

Newspaper publication of Unaudited Financial Results for the quarter and half year ended September 30 2025

Unaudited Financials Results Pursuant To Regulation 33 Of The SEBI(LODR) Regulations 2015 For The Quarter And Half Year Ended 30Th September 2025

14-Nov-2025 | Source : BSE

Unaudited Financial Statement for the Quarter and Half Year Ended 30th September 2025

Board Meeting Outcome for Unaudited Financial Statement For The Half-Year Ended 30Th September 2025

14-Nov-2025 | Source : BSE

Unaudited Financial Statement For The Half-Year Ended 30Th September 2025

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available